Skip to main content
Clinical Trials/DRKS00020413
DRKS00020413
Recruiting
N/A

Intermittent theta-burst stimulation (iTBS) as concomitant treatment for borderline personality disorder - a pilot study - DBTTMS

VR-Klinikum Düsseldorf, Kliniken der Heinrich-Heine-Universität0 sites60 target enrollmentJanuary 13, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
F60.31
Sponsor
VR-Klinikum Düsseldorf, Kliniken der Heinrich-Heine-Universität
Enrollment
60
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 13, 2020
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
VR-Klinikum Düsseldorf, Kliniken der Heinrich-Heine-Universität

Eligibility Criteria

Inclusion Criteria

  • Borderline Personality Disorder (DSM V) assessed through a standardized clinical interview (SKID V PD)
  • \- sufficient knowledge of German
  • \- Age: 18\-45
  • \- No prior treatment with DBT
  • \- If medicated stable treatment with the medication for 2 weeks before commendement of the brain stimulation treatment. Medication should remain stable during the 4\-weeks of brain stimulation.
  • \- Receiving inpatient or day\-clinic, standardized, DBT\-based treatment
  • \- Participants must be able to give consent to participate
  • \- Negative pregnancy test and being prepared to use contraception for the duration of brain stimulation treatment

Exclusion Criteria

  • \- history of seizures or epilepsy
  • \- metallic implants of the skull
  • \- extensive tatoos on the head
  • \- significant brain tumors or brain malformations
  • \- cerebrovascular events
  • \- traumatic brain injury
  • \- neurodegenerative disorders
  • \- brain surgery
  • \- deep brain stimulation
  • \- Pacemaker

Outcomes

Primary Outcomes

Not specified

Similar Trials